Global Swine Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
According to APO Research, The global Swine Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
This report presents an overview of global market for Swine Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Swine Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Swine Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Swine Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Swine Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio and Chopper Biology, etc.
Swine Vaccines segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Swine Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
According to APO Research, The global Swine Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
This report presents an overview of global market for Swine Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Swine Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Swine Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Swine Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Swine Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC, Tecon, Zoetis, Ceva, Hile Bio and Chopper Biology, etc.
Swine Vaccines segment by Company
- Merck
- Boehringer Ingelheim
- Jinyu Bio-Technology
- CAHIC
- Tecon
- Zoetis
- Ceva
- Hile Bio
- Chopper Biology
- WINSUN
- Hipra
- Ringpu Biology
- ChengDu Tecbond
- DHN
- CAVAC
- Virbac
- HVRI
- Bioveta
- CSF Vaccines
- FMD Vaccines
- Porcine Circovirus Vaccines
- PRRS Vaccines
- Others
- Government Tender
- Market Sales
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Swine Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Swine Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Swine Vaccines Market Size, 2019 VS 2023 VS 2030
1.3 Global Swine Vaccines Market Size Estimates and Forecasts (2019-2030)
1.4 Global Swine Vaccines Sales Estimates and Forecasts (2019-2030)
1.5 Global Swine Vaccines Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL SWINE VACCINES MARKET DYNAMICS
2.1 Swine Vaccines Industry Trends
2.2 Swine Vaccines Industry Drivers
2.3 Swine Vaccines Industry Opportunities and Challenges
2.4 Swine Vaccines Industry Restraints
3 SWINE VACCINES MARKET BY MANUFACTURERS
3.1 Global Swine Vaccines Revenue by Manufacturers (2019-2024)
3.2 Global Swine Vaccines Sales by Manufacturers (2019-2024)
3.3 Global Swine Vaccines Average Sales Price by Manufacturers (2019-2024)
3.4 Global Swine Vaccines Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Swine Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Swine Vaccines Manufacturers, Product Type & Application
3.7 Global Swine Vaccines Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Swine Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Swine Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Swine Vaccines Tier 1, Tier 2, and Tier
4 SWINE VACCINES MARKET BY TYPE
4.1 Swine Vaccines Type Introduction
4.1.1 CSF Vaccines
4.1.2 FMD Vaccines
4.1.3 Porcine Circovirus Vaccines
4.1.4 PRRS Vaccines
4.1.5 Others
4.2 Global Swine Vaccines Sales by Type
4.2.1 Global Swine Vaccines Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Swine Vaccines Sales by Type (2019-2030)
4.2.3 Global Swine Vaccines Sales Market Share by Type (2019-2030)
4.3 Global Swine Vaccines Revenue by Type
4.3.1 Global Swine Vaccines Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Swine Vaccines Revenue by Type (2019-2030)
4.3.3 Global Swine Vaccines Revenue Market Share by Type (2019-2030)
5 SWINE VACCINES MARKET BY APPLICATION
5.1 Swine Vaccines Application Introduction
5.1.1 Government Tender
5.1.2 Market Sales
5.2 Global Swine Vaccines Sales by Application
5.2.1 Global Swine Vaccines Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Swine Vaccines Sales by Application (2019-2030)
5.2.3 Global Swine Vaccines Sales Market Share by Application (2019-2030)
5.3 Global Swine Vaccines Revenue by Application
5.3.1 Global Swine Vaccines Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Swine Vaccines Revenue by Application (2019-2030)
5.3.3 Global Swine Vaccines Revenue Market Share by Application (2019-2030)
6 GLOBAL SWINE VACCINES SALES BY REGION
6.1 Global Swine Vaccines Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Swine Vaccines Sales by Region (2019-2030)
6.2.1 Global Swine Vaccines Sales by Region (2019-2024)
6.2.2 Global Swine Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Swine Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Swine Vaccines Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Swine Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Swine Vaccines Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Swine Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Swine Vaccines Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Swine Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Swine Vaccines Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL SWINE VACCINES REVENUE BY REGION
7.1 Global Swine Vaccines Revenue by Region
7.1.1 Global Swine Vaccines Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Swine Vaccines Revenue by Region (2019-2024)
7.1.3 Global Swine Vaccines Revenue by Region (2025-2030)
7.1.4 Global Swine Vaccines Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Swine Vaccines Revenue (2019-2030)
7.2.2 North America Swine Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Swine Vaccines Revenue (2019-2030)
7.3.2 Europe Swine Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Swine Vaccines Revenue (2019-2030)
7.4.2 Asia-Pacific Swine Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Swine Vaccines Revenue (2019-2030)
7.5.2 LAMEA Swine Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merck Swine Vaccines Product Portfolio
8.1.5 Merck Recent Developments
8.2 Boehringer Ingelheim
8.2.1 Boehringer Ingelheim Comapny Information
8.2.2 Boehringer Ingelheim Business Overview
8.2.3 Boehringer Ingelheim Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
8.2.5 Boehringer Ingelheim Recent Developments
8.3 Jinyu Bio-Technology
8.3.1 Jinyu Bio-Technology Comapny Information
8.3.2 Jinyu Bio-Technology Business Overview
8.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
8.3.5 Jinyu Bio-Technology Recent Developments
8.4 CAHIC
8.4.1 CAHIC Comapny Information
8.4.2 CAHIC Business Overview
8.4.3 CAHIC Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 CAHIC Swine Vaccines Product Portfolio
8.4.5 CAHIC Recent Developments
8.5 Tecon
8.5.1 Tecon Comapny Information
8.5.2 Tecon Business Overview
8.5.3 Tecon Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Tecon Swine Vaccines Product Portfolio
8.5.5 Tecon Recent Developments
8.6 Zoetis
8.6.1 Zoetis Comapny Information
8.6.2 Zoetis Business Overview
8.6.3 Zoetis Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Zoetis Swine Vaccines Product Portfolio
8.6.5 Zoetis Recent Developments
8.7 Ceva
8.7.1 Ceva Comapny Information
8.7.2 Ceva Business Overview
8.7.3 Ceva Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Ceva Swine Vaccines Product Portfolio
8.7.5 Ceva Recent Developments
8.8 Hile Bio
8.8.1 Hile Bio Comapny Information
8.8.2 Hile Bio Business Overview
8.8.3 Hile Bio Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Hile Bio Swine Vaccines Product Portfolio
8.8.5 Hile Bio Recent Developments
8.9 Chopper Biology
8.9.1 Chopper Biology Comapny Information
8.9.2 Chopper Biology Business Overview
8.9.3 Chopper Biology Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Chopper Biology Swine Vaccines Product Portfolio
8.9.5 Chopper Biology Recent Developments
8.10 WINSUN
8.10.1 WINSUN Comapny Information
8.10.2 WINSUN Business Overview
8.10.3 WINSUN Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 WINSUN Swine Vaccines Product Portfolio
8.10.5 WINSUN Recent Developments
8.11 Hipra
8.11.1 Hipra Comapny Information
8.11.2 Hipra Business Overview
8.11.3 Hipra Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Hipra Swine Vaccines Product Portfolio
8.11.5 Hipra Recent Developments
8.12 Ringpu Biology
8.12.1 Ringpu Biology Comapny Information
8.12.2 Ringpu Biology Business Overview
8.12.3 Ringpu Biology Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Ringpu Biology Swine Vaccines Product Portfolio
8.12.5 Ringpu Biology Recent Developments
8.13 ChengDu Tecbond
8.13.1 ChengDu Tecbond Comapny Information
8.13.2 ChengDu Tecbond Business Overview
8.13.3 ChengDu Tecbond Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
8.13.5 ChengDu Tecbond Recent Developments
8.14 DHN
8.14.1 DHN Comapny Information
8.14.2 DHN Business Overview
8.14.3 DHN Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 DHN Swine Vaccines Product Portfolio
8.14.5 DHN Recent Developments
8.15 CAVAC
8.15.1 CAVAC Comapny Information
8.15.2 CAVAC Business Overview
8.15.3 CAVAC Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 CAVAC Swine Vaccines Product Portfolio
8.15.5 CAVAC Recent Developments
8.16 Virbac
8.16.1 Virbac Comapny Information
8.16.2 Virbac Business Overview
8.16.3 Virbac Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 Virbac Swine Vaccines Product Portfolio
8.16.5 Virbac Recent Developments
8.17 HVRI
8.17.1 HVRI Comapny Information
8.17.2 HVRI Business Overview
8.17.3 HVRI Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 HVRI Swine Vaccines Product Portfolio
8.17.5 HVRI Recent Developments
8.18 Bioveta
8.18.1 Bioveta Comapny Information
8.18.2 Bioveta Business Overview
8.18.3 Bioveta Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.18.4 Bioveta Swine Vaccines Product Portfolio
8.18.5 Bioveta Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Swine Vaccines Value Chain Analysis
9.1.1 Swine Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Swine Vaccines Production Mode & Process
9.2 Swine Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Swine Vaccines Distributors
9.2.3 Swine Vaccines Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Swine Vaccines Market Size, 2019 VS 2023 VS 2030
1.3 Global Swine Vaccines Market Size Estimates and Forecasts (2019-2030)
1.4 Global Swine Vaccines Sales Estimates and Forecasts (2019-2030)
1.5 Global Swine Vaccines Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL SWINE VACCINES MARKET DYNAMICS
2.1 Swine Vaccines Industry Trends
2.2 Swine Vaccines Industry Drivers
2.3 Swine Vaccines Industry Opportunities and Challenges
2.4 Swine Vaccines Industry Restraints
3 SWINE VACCINES MARKET BY MANUFACTURERS
3.1 Global Swine Vaccines Revenue by Manufacturers (2019-2024)
3.2 Global Swine Vaccines Sales by Manufacturers (2019-2024)
3.3 Global Swine Vaccines Average Sales Price by Manufacturers (2019-2024)
3.4 Global Swine Vaccines Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Swine Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Swine Vaccines Manufacturers, Product Type & Application
3.7 Global Swine Vaccines Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Swine Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Swine Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Swine Vaccines Tier 1, Tier 2, and Tier
4 SWINE VACCINES MARKET BY TYPE
4.1 Swine Vaccines Type Introduction
4.1.1 CSF Vaccines
4.1.2 FMD Vaccines
4.1.3 Porcine Circovirus Vaccines
4.1.4 PRRS Vaccines
4.1.5 Others
4.2 Global Swine Vaccines Sales by Type
4.2.1 Global Swine Vaccines Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Swine Vaccines Sales by Type (2019-2030)
4.2.3 Global Swine Vaccines Sales Market Share by Type (2019-2030)
4.3 Global Swine Vaccines Revenue by Type
4.3.1 Global Swine Vaccines Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Swine Vaccines Revenue by Type (2019-2030)
4.3.3 Global Swine Vaccines Revenue Market Share by Type (2019-2030)
5 SWINE VACCINES MARKET BY APPLICATION
5.1 Swine Vaccines Application Introduction
5.1.1 Government Tender
5.1.2 Market Sales
5.2 Global Swine Vaccines Sales by Application
5.2.1 Global Swine Vaccines Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Swine Vaccines Sales by Application (2019-2030)
5.2.3 Global Swine Vaccines Sales Market Share by Application (2019-2030)
5.3 Global Swine Vaccines Revenue by Application
5.3.1 Global Swine Vaccines Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Swine Vaccines Revenue by Application (2019-2030)
5.3.3 Global Swine Vaccines Revenue Market Share by Application (2019-2030)
6 GLOBAL SWINE VACCINES SALES BY REGION
6.1 Global Swine Vaccines Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Swine Vaccines Sales by Region (2019-2030)
6.2.1 Global Swine Vaccines Sales by Region (2019-2024)
6.2.2 Global Swine Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Swine Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Swine Vaccines Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Swine Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Swine Vaccines Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Swine Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Swine Vaccines Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Swine Vaccines Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Swine Vaccines Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL SWINE VACCINES REVENUE BY REGION
7.1 Global Swine Vaccines Revenue by Region
7.1.1 Global Swine Vaccines Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Swine Vaccines Revenue by Region (2019-2024)
7.1.3 Global Swine Vaccines Revenue by Region (2025-2030)
7.1.4 Global Swine Vaccines Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Swine Vaccines Revenue (2019-2030)
7.2.2 North America Swine Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Swine Vaccines Revenue (2019-2030)
7.3.2 Europe Swine Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Swine Vaccines Revenue (2019-2030)
7.4.2 Asia-Pacific Swine Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Swine Vaccines Revenue (2019-2030)
7.5.2 LAMEA Swine Vaccines Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Merck Swine Vaccines Product Portfolio
8.1.5 Merck Recent Developments
8.2 Boehringer Ingelheim
8.2.1 Boehringer Ingelheim Comapny Information
8.2.2 Boehringer Ingelheim Business Overview
8.2.3 Boehringer Ingelheim Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
8.2.5 Boehringer Ingelheim Recent Developments
8.3 Jinyu Bio-Technology
8.3.1 Jinyu Bio-Technology Comapny Information
8.3.2 Jinyu Bio-Technology Business Overview
8.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
8.3.5 Jinyu Bio-Technology Recent Developments
8.4 CAHIC
8.4.1 CAHIC Comapny Information
8.4.2 CAHIC Business Overview
8.4.3 CAHIC Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 CAHIC Swine Vaccines Product Portfolio
8.4.5 CAHIC Recent Developments
8.5 Tecon
8.5.1 Tecon Comapny Information
8.5.2 Tecon Business Overview
8.5.3 Tecon Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 Tecon Swine Vaccines Product Portfolio
8.5.5 Tecon Recent Developments
8.6 Zoetis
8.6.1 Zoetis Comapny Information
8.6.2 Zoetis Business Overview
8.6.3 Zoetis Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.6.4 Zoetis Swine Vaccines Product Portfolio
8.6.5 Zoetis Recent Developments
8.7 Ceva
8.7.1 Ceva Comapny Information
8.7.2 Ceva Business Overview
8.7.3 Ceva Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.7.4 Ceva Swine Vaccines Product Portfolio
8.7.5 Ceva Recent Developments
8.8 Hile Bio
8.8.1 Hile Bio Comapny Information
8.8.2 Hile Bio Business Overview
8.8.3 Hile Bio Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.8.4 Hile Bio Swine Vaccines Product Portfolio
8.8.5 Hile Bio Recent Developments
8.9 Chopper Biology
8.9.1 Chopper Biology Comapny Information
8.9.2 Chopper Biology Business Overview
8.9.3 Chopper Biology Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.9.4 Chopper Biology Swine Vaccines Product Portfolio
8.9.5 Chopper Biology Recent Developments
8.10 WINSUN
8.10.1 WINSUN Comapny Information
8.10.2 WINSUN Business Overview
8.10.3 WINSUN Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.10.4 WINSUN Swine Vaccines Product Portfolio
8.10.5 WINSUN Recent Developments
8.11 Hipra
8.11.1 Hipra Comapny Information
8.11.2 Hipra Business Overview
8.11.3 Hipra Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.11.4 Hipra Swine Vaccines Product Portfolio
8.11.5 Hipra Recent Developments
8.12 Ringpu Biology
8.12.1 Ringpu Biology Comapny Information
8.12.2 Ringpu Biology Business Overview
8.12.3 Ringpu Biology Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.12.4 Ringpu Biology Swine Vaccines Product Portfolio
8.12.5 Ringpu Biology Recent Developments
8.13 ChengDu Tecbond
8.13.1 ChengDu Tecbond Comapny Information
8.13.2 ChengDu Tecbond Business Overview
8.13.3 ChengDu Tecbond Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
8.13.5 ChengDu Tecbond Recent Developments
8.14 DHN
8.14.1 DHN Comapny Information
8.14.2 DHN Business Overview
8.14.3 DHN Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.14.4 DHN Swine Vaccines Product Portfolio
8.14.5 DHN Recent Developments
8.15 CAVAC
8.15.1 CAVAC Comapny Information
8.15.2 CAVAC Business Overview
8.15.3 CAVAC Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.15.4 CAVAC Swine Vaccines Product Portfolio
8.15.5 CAVAC Recent Developments
8.16 Virbac
8.16.1 Virbac Comapny Information
8.16.2 Virbac Business Overview
8.16.3 Virbac Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.16.4 Virbac Swine Vaccines Product Portfolio
8.16.5 Virbac Recent Developments
8.17 HVRI
8.17.1 HVRI Comapny Information
8.17.2 HVRI Business Overview
8.17.3 HVRI Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.17.4 HVRI Swine Vaccines Product Portfolio
8.17.5 HVRI Recent Developments
8.18 Bioveta
8.18.1 Bioveta Comapny Information
8.18.2 Bioveta Business Overview
8.18.3 Bioveta Swine Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
8.18.4 Bioveta Swine Vaccines Product Portfolio
8.18.5 Bioveta Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Swine Vaccines Value Chain Analysis
9.1.1 Swine Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Swine Vaccines Production Mode & Process
9.2 Swine Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Swine Vaccines Distributors
9.2.3 Swine Vaccines Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
